SIRT3 and diffuse large B-cell lymphoma: YC8-02 inhibits the TCA cycle in Diffuse large B cell lymphomas (DLBCL) by preventing the decrease of glutamate dehydrogenase and acetyl-CoA through SIRT3, leading to autophagic cell death and suppression of DLBCL cell proliferation 70.